Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

(18F)AV-133

Known as: 18F-AV-133, Fluorine F 18-AV-133 
A radioconjugate composed of the vesicular monoamine transporter 2 (VMAT2) targeting agent AV-133, a dihydrotetrabenazine analog, labeled with the… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
OBJECTIVE Recent studies suggest that constipation is not only a clinical marker of premotor phase in Parkinson's disease (PD… Expand
Is this relevant?
2018
2018
Objectives To further validate the diagnostic utility of 18F-AV-133 vesicular monoamine transporter type 2 (VMAT2) positron… Expand
Is this relevant?
2017
2017
Idiopathic Parkinson disease is a common neurodegenerative disorder for which misdiagnosis occurs in up to 30% of patients after… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
2014
2014
BackgroundBiomarkers based on the underlying pathology of Alzheimer’s disease (AD) and Dementia with Lewy Bodies (DLB) have the… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2014
2014
Imaging targeting vesicular monoamine transporter (VMAT2) alterations is a sensitive tool for early diagnosis of Parkinson’s… Expand
  • figure 1
  • figure 2
  • figure 3
  • table I
  • figure 4
Is this relevant?
2011
2011
UNLABELLED (18)F-9-fluoropropyl-(+)-dihydrotetrabenazine ((18)F-AV-133) is a novel positron emission tomography tracer for… Expand
Is this relevant?
Highly Cited
2010
Highly Cited
2010
PET provides a noninvasive means to evaluate the functional integrity of the presynaptic monoaminergic system in the living human… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2010
2010
Vesicular monoamine transporter 2 (VMAT2) is highly expressed in the endocrine cells and brain. We investigated the… Expand
  • table 1
  • figure 2
  • figure 1
  • table 2
  • figure 3
Is this relevant?